Author:
Rosenquist Peter B.,Youssef Nagy A.,Surya Sandarsh,McCall William V.
Funder
NIMH
American Foundation for Suicide Prevention
Lumosity Corporation
Merck
ALS Association
GlaxoSmithKline
Harvard Stem Cell Institute
Neurologic Clinical Research Institute
MECTA Corporation
ABR Corporation
Veterans Administration
Subject
Psychiatry and Mental health
Reference64 articles.
1. The FDA and ECT;McDonald;J ECT,2016
2. U.S. Department of Health and Human Services Food and Drug Administration. Electroconvulsive therapy (ECT) devices for class II intended uses. Rockville (MD): 2015. Available at: https://www.gpo.gov/fdsys/pkg/FR-2015-32592.pdf. Accessed May 1, 2018.
3. Off-label prescribing among office-based physicians;Radley;Arch Intern Med,2006
4. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009;Kreyenbuhl;Schizophr Bull,2010
5. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance;Hasan;World J Biol Psychiatry,2012
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献